Khalil Sultanem

Department Of Otolaryngology Head And Neck Surgery
Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Neoadjuvant Capecitabine in Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Neoadjuvant Capecitabine in Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.

Journal: JAMA dermatology

Published: May 27, 2026

Phase I/II Trial of Durvalumab plus Tremelimumab and Stereotactic Body Radiotherapy for Metastatic Head and Neck Carcinoma.

Phase I/II Trial of Durvalumab plus Tremelimumab and Stereotactic Body Radiotherapy for Metastatic Head and Neck Carcinoma.

Journal: International journal of radiation oncology, biology, physics

Published: February 10, 2026

What Is the Impact of Treatment De-Escalation on Patient-Reported Outcomes in Patients With T1-T2 Oropharyngeal Cancers? A Secondary Analysis of the ORATOR Studies.

What Is the Impact of Treatment De-Escalation on Patient-Reported Outcomes in Patients With T1-T2 Oropharyngeal Cancers? A Secondary Analysis of the ORATOR Studies.

Journal: International journal of radiation oncology, biology, physics

Published: November 30, 2025

Toward a Typology of Patients With Head and Neck Cancer: Biopsychosocial Profiles Predicting Longitudinal Quality of Life.

Toward a Typology of Patients With Head and Neck Cancer: Biopsychosocial Profiles Predicting Longitudinal Quality of Life.

Journal: Head & neck

Published: October 20, 2025

Guidelines for Clinicians and Pathologists on Performing Skin Biopsies and Reporting on Suspected Cutaneous Squamous Cell Carcinoma.

Guidelines for Clinicians and Pathologists on Performing Skin Biopsies and Reporting on Suspected Cutaneous Squamous Cell Carcinoma.

Journal: Current oncology (Toronto, Ont.)

Published: September 30, 2025

Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk index.

Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk index.

Journal: Oral oncology

Published: August 29, 2025

Randomized Controlled Trial of the Meaning-Making Intervention (MMi) in Patients Newly Diagnosed With Advanced Cancer: Full Trial.

Randomized Controlled Trial of the Meaning-Making Intervention (MMi) in Patients Newly Diagnosed With Advanced Cancer: Full Trial.

Journal: Psycho-oncology

Published: August 29, 2025

Oral Cavity Squamous Cell Carcinoma in Young Patients: A Multi-Institutional Study of the Canadian Head & Neck Collaborative Research Initiative.

Oral Cavity Squamous Cell Carcinoma in Young Patients: A Multi-Institutional Study of the Canadian Head & Neck Collaborative Research Initiative.

Journal: Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale

Published: August 22, 2025

Prognostic data extraction harnessing a privacy-preserving large language model: a clinician-AI collaborative retrospective evaluation in head and neck oncology.

Prognostic data extraction harnessing a privacy-preserving large language model: a clinician-AI collaborative retrospective evaluation in head and neck oncology.

Journal: NPJ precision oncology

Published: July 21, 2025

Geriatric Nutritional Risk Index Predicts Treatment Intolerance and Survival in Head and Neck Cancer.

Geriatric Nutritional Risk Index Predicts Treatment Intolerance and Survival in Head and Neck Cancer.

Journal: Head & neck

Published: July 13, 2025

Preoperative Clinical and Tumor Factors Associated With Adjuvant Therapy for Oral Cavity Cancer.

Preoperative Clinical and Tumor Factors Associated With Adjuvant Therapy for Oral Cavity Cancer.

Journal: JAMA otolaryngology-- head & neck surgery

Published: March 27, 2025

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study.

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study.

Journal: Head & neck

Published: March 23, 2025

Showing 1-12 of 61

Last Updated: 09/26/2026